125I-CSF-1 Transfer to Fetal/Placental Tissues After Maternal Intravenous Administration
| Tissue . | Time Postinjection-150 . | |
|---|---|---|
| 5 min . | 10 min . | |
| Fetal | 0.27 ± 0.03 (n = 10) | 0.48 ± 0.07 (n = 10) |
| Placental | 0.45 ± 0.07 (n = 10) | 0.38 ± 0.06 (n = 10) |
| Tissue . | Time Postinjection-150 . | |
|---|---|---|
| 5 min . | 10 min . | |
| Fetal | 0.27 ± 0.03 (n = 10) | 0.48 ± 0.07 (n = 10) |
| Placental | 0.45 ± 0.07 (n = 10) | 0.38 ± 0.06 (n = 10) |
Results are expressed as the percentage of injected cpm ± SEM.
Day-17 gestation pregnant female mice received 1 × 106cpm 125I-CSF-1 (∼300,000 cpm/ng) intravenously and were killed at the indicated times after the injection. 125I-cpm in whole fetuses and placentas was determined.